Search NLS News

Positive results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) versus current standard-of-care abiraterone as a 1st-line treatment for patients with metastatic castration-resistant prostate cancer (mCRPC) with or without homologous recombination repair (HRR) gene mutations. “This […]

A new study by an international consortium, including researchers from Stockholm University, looking at the presence of pharmaceuticals in the world’s rivers, found concentrations at potentially toxic levels in more than a quarter of the locations studied. The new study, published in Proceedings of the National Academy of Sciences, is the first truly global-scale investigation […]

The two companies have signed an agreement with the goal of offering broader and more patient-centric blood sampling solutions for the Attana AVATM system starting with COVID-19 immune profiling. Since November 2021, Attana has been performing comparative studies of finger stick capillary blood samples simultaneously collected by both test tubes and Capitainer qDBS cards (quantitative […]

The basic conditions has changed and due to the current stock exchange developments it is not possible to carry out the deal. Read more: AegirBio to acquire Dynamic Code Photo of Anne Kihlgren, founder of Dynamic Code

Vicore Pharma has announced data from an interim analysis suggesting that C21 stabilizes disease and increases lung function in idiopathic pulmonary fibrosis (IPF) patients as quantified by standard FVC (Forced Vital Capacity) measurement. An interim analysis of the phase 2 proof-of-concept study in IPF (the AIR1study) showed an initial stabilization of disease and then an […]

Bactiguard and Zimmer Biomet have agreed to expand the global license partnership, that was initiated in 2019, to cover multiple product segments. The extended exclusive license agreement covers implants for joint reconstruction (hips and knees), sports medicine, craniomaxillofacial and thoracic applications. License and development fees of 1.5 million USD payable in 2022 It includes license […]

Scientific Advisor Henning Beck Nielsen, as well as COO Lars B. Rasmussen have both decided to step out of their current PILA roles to focus more on other projects outside the company. “I, sincerely, thank them both for their tremendous contribution in developing PILA to its current stage. Together with Henning Beck-Nielsen we laid out […]

Our latest issue, No 01 2022, is out – sign up for a subscription today and stay updated on the Nordic life science industry’s latest progress and challenges. This Nobel Prize Special issue includes exclusive interviews with the Laureates in Chemistry and Medicine 2021, as well as in-depth stories about the Nobel discoveries and their […]

Five proposals for activities aiming to promote Nordic clinical research cooperation related to international activities have been granted support from the Nordic Trial Alliance at NordForsk. The activities are intended to move Nordic collaboration within certain areas of clinical studies forward, strengthen knowledge transfer and have a concrete outcome that will enhance Nordic clinical research […]

The European Patent Office has granted a further European patent to the company, entitled “Antigen and method for production thereof”. The granted European patent follows the approval of the US-member of this patent family already in 2018 under US Patent 10,159,729 B2. “We’re excited about this important milestone that provides additional protection for our core […]